Moving towards the future of consumer-managed healthcare
If there were any doubts about the increased role of digital connections in our healthcare system post-pandemic, they are dashed by the proposed $18.5 billion merger between Teledoc and Livongo. The combination of telehealth and chronic disease management services will open up virtual care to a broader range of conditions, such as mental health, where the need is great. Data from the CDC highlights the significant mental health challenges related to the COVID-19 pandemic; the role which digital solutions can play in removing barriers to care in the mental health space was affirmed by the FDA in their recent guidance, which is intended to expand the availability of digital health devices for treating psychiatric disorders during the pandemic. On the heels of this guidance, Orexo (Sweden) accelerated the launch of two digital therapies for the treatment of depression and alcohol misuse.
Evidence for digitally-enabled care is building, including a recently published retrospective study that showed how a 12-week digitally-deployed cognitive behavioral therapy improved symptoms of mild-to-moderate depression and/or anxiety, with improvements maintained for up to 9 months. As consumers grow accustomed to real-time access to care, a recent paper discusses how other patient touchpoints, such as the provider and payer, will need to adapt how they collect, analyze, and share data. While a survey from the Alliance of Community Health Plans (ACHP) and the Academy of Managed Care Pharmacy (AMCP) found a surge in the use of telehealth services since the start of the pandemic, a pre-pandemic report from Accenture suggests that the breadth and longevity of virtual healthcare services will depend in large part on the consumer’s trust in the security of their data, and the quality of their initial digital experience.
Creating Value from Next-Generation Real-World Evidence | McKinsey & Company
The starter pistol for the virtual care platforms race | Rock Health
The Promise of Digital Therapeutics | McKinsey & Company
Research: In partnership with University of Southern California Schaeffer Center and the RAND Corporation, Evidation Health has been awarded a four-year NIH R01 Research Project Grant to develop a representative digital health dataset and generalizable data science methodologies that account for all socio-demographic groups, including the historically underserved. Read more about the grant here.
Report: As part of the Foundation for National Institutes of Health Biomarker consortium, Evidation leaders participated in a recent workshop to discuss the opportunities and challenges of remote digital monitoring for medical product development, and published a summary report.
Partners: We had a great discussion with Omada about the importance of decentralized clinical trials and differentiated data in research. Listen to the discussion on the Rock Health podcast, with Evidation’s Executive Director of Digital Health Outcomes, Dr. Jessie Juusola, Omada Health’s Senior Director of Clinical Research & Policy, Dr. Cynthia Castro Sweet, and Rock Health’s CEO & Managing Director, Bill Evans.
IQVIA and Evidation have partnered to advance traditional real-world evidence strategies with differentiated person generated health data. Listen to a discussion with IQVIA about how to improve the quality and impact of RWE studies and evidence generation through connected devices and person generated health data in IQVIA MedTech’s Webinar Series, “Digital Health in the Real World: Maximizing the use of real world evidence from code to commercialization”.
Point of View: The future of healthcare requires a direct connection to patients to better understand their lived experiences. Learn more about Evidation’s view on how biopharma organizations are generating better evidence through person-generated health data from direct patient connections, featured in STAT. Read the article here.